Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 17 Aug 2026 for Rhythm Pharmaceuticals, INC., €202k.
Filing timeline
BuySaleAlastair Garfield
Insider track record
Disclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Alastair Garfield: trading record in brief
This profile gathers the share dealings of Alastair Garfield in Rhythm Pharmaceuticals, Inc. We count 9 filings; the first trade dates from 1 July 2025 and the latest from 13 August 2026.
On the market, this insider has only sold: 6 sales, €864k in total. The rest of the record consists of 1 share grant and 2 option exercises. So far in 2026, the count stands at no purchases and 4 sales.
The record was last updated on 17 August 2026 with an open-market sale (€158k) in Rhythm Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Alastair Garfield
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
2,007 shares@ US$116.10930.0029% mcap25.5% of flowCommon StockSEC:0001649904-26-000013:0
1,556 shares@ US$117.07590.0023% mcap20.0% of flowCommon StockSEC:0001649904-26-000013:1
3,400 shares@ US$118.28430.0051% mcap44.1% of flowCommon StockSEC:0001649904-26-000013:2
800 shares@ US$119.16880.0012% mcap10.4% of flowCommon StockSEC:0001649904-26-000013:3
6,663 sharesCommon StockSEC:0001104659-26-009764:0
4,445 sharesCommon StockSEC:0001104659-25-065844:0
6 of 6 declarations
